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Background: An immunoinhibitory receptor, programmed death-1 (PD-1), and its ligand, programmed
death-ligand 1 (PD-L1), are involved in immune evasion mechanisms for several pathogens causing chronic
infections and for neoplastic diseases. However, little has been reported for the functions of these molecules in
chickens. Thus, in this study, their expressions and roles were analyzed in chickens infected with Marek’s disease
virus (MDV), which induces immunosuppression in infected chickens.
Results: A chicken T cell line, Lee1, which constitutively produces IFN-γ was co-cultured with DF-1 cells, which
is a spontaneously immortalized chicken fibroblast cell line, transiently expressing PD-L1, and the IFN-γ expression
level was analyzed in the cell line by real-time RT-PCR. The IFN-γ expression was significantly decreased in Lee1
cells co-cultured with DF-1 cells expressing PD-L1. The expression level of PD-1 was increased in chickens at the
early cytolytic phase of the MDV infection, while the PD-L1 expression level was increased at the latent phase.
In addition, the expression levels of PD-1 and PD-L1 were increased at tumor lesions found in MDV-challenged
chickens. The expressions levels of PD-1 and PD-L1 were also increased in the spleens and tumors derived from
MDV-infected chickens in the field.
Conclusions: We demonstrated that the chicken PD-1/PD-L1 pathway has immunoinhibitory functions, and PD-1
may be involved in MD pathogenesis at the early cytolytic phase of the MDV infection, whereas PD-L1 could
contribute to the establishment and maintenance of MDV latency. We also observed the increased expressions of
PD-1 and PD-L1 in tumors from MDV-infected chickens, suggesting that tumor cells transformed by MDV highly
express PD-1 and PD-L1 and thereby could evade from immune responses of the host.Background
Marek’s disease (MD) is a viral lymphoproliferative dis-
ease of chickens caused by a cell-associated herpesvirus,
Marek’s disease virus (MDV; family Herpesviridae, sub-
family Alphaherpesvirinae, genus Mardivirus, species
Gallid Herpesvirus 2 (GaHV-2)) [1]. MDV strains are
classified into 3 serotypes, GaHV-2 (MDV serotype 1:
MDV-1), Gallid herpesvirus 3 (MDV serotype 2: MDV-2)
and Meleagrid herpesvirus 1 (MDV serotype 3 or herpes-
viru of turkeys (HVT)), and MD is caused by serotype1
MDV strains except for attenuated vaccine strains [1].* Correspondence: okazu@vetmed.hokudai.ac.jp
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distribution, and reproduction in any mediumThe pathogenesis of MD can be sequentially divided into
3 phases: early cytolytic phase, latent phase, and second-
ary cytolytic phase with immunosuppression and tumor
development. In the early cytolytic phase, MDV-1 causes
lytic infection of lymphoid cells, mainly B cells that last
for up to six days after infection [2]. Then, this cytolytic
infection induces the activation of T cells, and MDV
establishes latency in a part of the activated CD4+ T cells
at 1–2 weeks after infection. In the latent phase, infected
chickens show no clinical signs, but cellular immunity is
continually inhibited by apoptosis of CD4+ T cells, CD8-
down regulation in CD8+ T cells, decrease in the respon-
siveness to the stimulation through T cell receptor (TCR)
in CD4+ and CD8+ T cells and MHC class I-down regula-
tion at 2–3 weeks after infection [3,4]. In the secondaryd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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CD4+ T cells, and develops malignant lymphomas. The
main targets for the transformation by MDV-1 are CD4+
T cells, suggesting that latent infection in this T cell sub-
set is intimately related to the subsequent transformation
by MDV-1 [1]. Several viral factors which could contrib-
ute to the oncogenicity and pathogenicity of MDV-1 have
been identified. Among them, a viral protein, Meq, is the
most important factor involved in MDV-1 oncogenicity
[5-8]. Meq is only present in MDV-1 strains and is abun-
dantly expressed in MDV-1-transformed cell lines and
tumor samples. The overexpression of Meq in rodent and
chicken fibroblast cell lines resulted in morphological
changes of the cells and protection of the cells from apop-
tosis [6,7]. A Meq-deficient mutant virus was completely
non-oncogenic [8]. These observations suggest that Meq
plays a key role in the oncogenicity of MDV-1. However,
the precise molecular mechanism of MDV-1 oncogenicity
and pathogenicity remains to be established due to the lack
of appropriate T cell transformation systems in chickens.
Currently, MD is well controlled by the vaccination
with MDV-1 strains, apathogenic MDV-2 strains and/or
HVT. However, MDV-1 strains in the field tend to
increase their virulence, and increased numbers of MD
cases have been reported even in vaccinated chickens
[9]. Therefore, the development of more effective vac-
cines would be desirable, since future outbreaks of
MDV-1 could occur [9]. However, the detailed mechan-
isms for the protection by vaccines are still unknown.
It has been known that cell-mediated immunity is effect-
ive for the inhibition of MDV-1 propagation and onco-
genicity [10]. The immune responses induced by MDV-1
inhibit virus propagation, whereas an excess of inflam-
matory response induces immunosuppression through a
negative feedback mechanism, and subsequently contri-
butes to MDV-1 reactivation from latency [11]. Thus,
the host immune responses in infected chickens are also
involved in the pathogenesis of MDV-1.
Persistent viral infections often result in T cell exhaus-
tion. During chronic viral infection, such as human
immunodeficiency virus (HIV) and hepatitis C virus
(HCV), antigen-specific CD8+ T cells initially obtain
functional activities but gradually become dysfunctional
as the infection progresses, and exhausted CD8+ T cells
are unable to produce sufficient cytokines [12,13]. An
immune inhibitory receptor, programmed death 1 (PD-1)
and its ligand, programmed death ligand 1 (PD-L1), have
been reported as molecules involved in T cell exhaustion
[14]. PD-1 and PD-L1 belong to the B7-CD28 super-
family, and PD-1 is expressed on the membrane of acti-
vated T cells and B cells, while PD-L1 is constitutively
expressed on the membrane of activated T cells, dendritic
cells (DCs), macrophages, and a wide range of non-
hematopoietic cells [15,16]. PD-1 expression is upregulatedon CD8+ T cells specific for cells chronically infected with
human T-cell lymphotropic virus type 1 (HTLV-1) [17].
The increase in PD-L1 expression was observed in
cells infected with hepatitis B virus, HIV, and HTLV-1
[17-19]. In addition, the PD-1/ PD-L1 pathway plays a
crucial role in immune evasion by tumor cells, such as
pancreatic cancer and adult T-cell leukemia [15,16].
Chicken PD-1 and PD-L1 shared 58% and 54.5%
amino acid identities with human PD-1 and PD-L1,
respectively, and the chicken PD-1/PD-L1 pathway
may also play roles in the immunoinhibitory functions.
Recently, it has been reported that the expression levels
of PD-1 and PD-L2 mRNA on CD4+ T cells were
increased in the secondary cytolytic phase of the MDV-1
infection [20]. PD-L2, as well as PD-L1, belongs to the
B7-CD28 superfamily, and is known to carry the immu-
noinhibitory functions by the interaction with PD-1 [21].
However, the PD-1/PD-L1 pathway usually serves as an
immunoinhibitory molecule in human and murine dis-
eases such as chronic infections and tumors, but not
PD-L2. Therefore, it is necessary to analyze the expres-
sions of PD-1 and PD-L1 in MDV-1-infected chickens
and MD-derived tumors to properly know the roles of
chicken immunoinhibitory molecules in MD pathogen-
esis and tumorigenesis. In this study, we evaluated the
immunosuppressive functions of the PD-1/PD-L1 path-
way, and analyzed the expression kinetics of the immu-
noinhibitory molecules in the spleens, peripheral blood
mononuclear cells (PBMCs), and tumors of MDV-
infected chickens. These results suggest that the chicken
PD-1/PD-L1 pathway has immunosuppressive functions,
and PD-1 and PD-L1 may contribute to MD pathogen-
esis and tumorigenesis.
Results
Evaluation of the immunoinhibitory function of the
PD-1/PD-L1 pathway
In order to clarify the immunoinhibitory functions of
chicken PD-1 and PD-L1, the expression level of IFN-γ
mRNA was measured in a chicken T cell line co-
cultured with cells expressing PD-L1. First, we measured
the level of PD-1 mRNA expression in three chicken T
cell lines, MSB1 and HP1, which were transformed by
MDV-1, and Lee1, which was transformed by reticuloen-
dotheliosis virus (REV), and PBMCs obtained from a
healthy chicken (Figure 1A). PD-1 mRNA was highly
expressed in Lee1 cells compared to other cells, and
thus, Lee1 cells were used to evaluate the immunosup-
pressive functions of PD-1 and PD-L1. In this assay, we
quantified the expression of IFN-γ mRNA in Lee1 cells
after the co-culture with a chicken fibroblast cell line, DF-
1, transfected with PD-L1-expressing vector, pCMV-PDL1
(Figure 1B), since REV-transformed T cells are known







































Figure 1 (See legend on next column.)
Figure 1 Analysis of immunoinhibitory functions by chicken
PD-1/PD-L pathway. (A) The expression of PD-1 mRNA was
determined in MSB1, HP1, Lee1 cell, and PBMCs from uninfected
chickens by real-time RT-PCR. The degree of the PD-1 mRNA
expression was expressed relative to the mean basal value in PBMCs
after normalization to that of β-actin mRNA. (B) The expression
levels of IFN-γ mRNA in Lee1 cells co-cultured with DF-1 cells were
determined by real-time RT-PCR. DF-1 cells were transfected with
pCMV-Tag1 or pCMV-PDL1. The degree of the PD-1 and IFN-γ mRNA
expression was expressed relative to the mean basal value in the
presence of pCMV-Tag1 after normalization to that of β-actin mRNA.
Three independent experiments were performed in triplicate. Error
bars indicate standard deviations. The significant differences were
determined by Student’s paired t-test between types of expression
plasmids (*P< 0.05). (C) Transient expression of PD-L1 construct in
DF-1 cells was determined by western blotting. Blots were also
probed with an anti-actin monoclonal antibody as a loading control.
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pCMV-PDL1-transfected DF-1 cells compared to pCMV-
Tag1-transfected DF-1 cells. The transient expression of
PD-L1 in pCMV-PDL1-transfected DF-1 cells was con-
firmed by Western blotting (Figure 1C). These results
suggest that the PD-1/PD-L1 pathway exhibits the im-
munosuppressive functions.MDV loads and the expressions of PD-1, PD-L1, IFNγ,
and meq mRNA in experimentally infected chickens
To investigate whether immunoinhibitory molecules are
involved in MD pathogenesis, we analyzed viral loads
and expression levels of host and viral genes in the
spleens of MDV-1-infected chickens. First, the MDV-1
genome loads were quantified at 3, 7, 10, 14, 21, 28, and
35 day post inoculation (d.p.i) (Figure 2). The MDV-1
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Figure 2 Viral loads in spleens from chickens experimentally
infected with MDV-1. Chickens were inoculated with 2,000 PFU
of RB1B (n= 36). Spleens were collected from MDV-1-infected and
uninfected chickens at 3, 7, 10, 14, 21, 28, and 35 d.p.i., and four
samples were prepared at each time point. Viral loads in the
spleens were determined by real-time PCR targeting the meq gene.
The results are shown as ratios between concentrations of the
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Figure 3 The mRNA expressions of PD-1 and PD-L1 in the
spleens from chickens experimentally infected with MDV-1.
The expressions of PD-1 (A), PD-L1 (B), IFN-γ (C), and meq (D) mRNA
were determined by real-time RT-PCR. The results are presented as
mean and standard deviations in each schedule. The concentration
of each mRNA (A-C) was normalized to that of β-actin mRNA.
The extent of gene expression (−fold) was calculated by dividing
the value of each sample by that of each control. The significant
differences were determined by Student’s t-test (*P< 0.05).
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load was increased at 14 d.p.i., decreased slightly at 21 d.
p.i., and increased again at 28 d.p.i. In our experiments,
based on the amounts of the MDV-1 genome at each
time point after virus inoculation, we determined each
phase of the MDV infection: the early cytolytic phase
(7–14 d.p.i.), the latent phase (14–28 d.p.i.), and the sec-
ondary cytolytic phase (after 28 d.p.i.). The expression of
PD-1 mRNA was upregulated in the early cytolytic
phase, whereas the expression of PD-L1 mRNA was
transiently increased in the early cytolytic phase (at 7
d.p.i.) and increased again in the latent phase (at 21 d.p.i.)
(Figure 3A, B). Since IFN-γ could be involved in the
expressions of PD-1 and PD-L1 [14,15], the expression of
IFN-γ mRNA was also analyzed (Figure 3C). The expres-
sion of IFN-γ mRNA was increased in the early
infection phase (at 7–14 d.p.i.), decreased in the latent phase
following the increase in the expression of PD-L1 mRNA,
and increased again in the secondary cytolytic phase.
In recent studies, it was reported that the HIV
accessory protein Nef or the HCV core protein could
upregulate PD-1 expression [23,24]. Since an MDV-1
oncoprotein, Meq, contributes to oncogenicity by alter-
ing the expression of various cellular genes [6] and also
plays an important role in the induction of immunosup-
pression [25], Meq may be involved in the expression of
PD-1 in MDV-1-infected chicken. In addition, Meq is
abundantly expressed in latently-infected cells and
tumor cells [5], and therefore, Meq may be also involved
in the expression of PD-L1. Thus, we analyzed the
expression of meq mRNA in each phase of the infec-
tion (Figure 3D). The expression of meq mRNA was
increased at 14 d.p.i., and this expression kinetics were
similar to those of PD-1 mRNA in the early cytolytic
phase. However, the expression of meq mRNA was
increased again in the secondary cytolytic phase, unlike
the kinetics of PD-1 mRNA, because MDV-1 was reacti-
vated following the disease progression (Figure 2).
Expressions of PD-1, PD-L1, IFNγ, and meq mRNA
in tumor lesions
To examine if immunoinhibitory molecules could be
involved in tumor formation by MDV-1, the mRNA
expressions of PD-1, PD-L1, IFN-γ, and meq were
analyzed in tumor lesions observed in kidneys of experi-
mentally infected chickens (Figure 4). The expressions of
PD-1 and IFN-γ in tumor lesions were significantly
increased, and the mean degree of the expression of PD-
L1 was increased although the difference was not statis-
tically significant. In addition, the expressions of PD-1
and PD-L1 in tumor lesions were compared with those
in PBMCs obtained from experimentally infected chick-
ens (Additional file 1: Figure S1). The expressions of
PD-1 and PD-L1 in tumor lesions were significantlyincreased compared to those in PBMCs. These results
suggest that PD-1 and PD-L1 were expressed on tumor
cells caused by MDV-1. In tumor cells, there was a posi-
tive correlation between meq and PD-1 mRNA expres-
























































Figure 5 A positive correlation between each of the gene
expressions in MD-derived tumor samples. These data are
shown correlations between gene expressions of meq and PD-1 (A),





























































Figure 4 The mRNA expressions of PD-1 and PD-L1 in tumor
lesions observed in kidneys of chickens experimentally infected
with MDV-1. A total of 9 tumor samples were collected at 21, 28,
and 35 d.p.i. (n= 2, 3, and 4, respectively). Two kidney samples were
also collected from uninfected chickens and analyzed as controls.
The expressions of PD-1 (A), PD-L1 (B), IFN-γ (C), and meq (D) mRNA
were determined by real-time RT-PCR. The concentration of each
mRNA was normalized to that of β-actin mRNA. The extent of gene
expression (−fold) was calculated by dividing the value of each
sample by that of the value of each control (A-D). Error bars
represent standard deviations. The significant differences were
determined by Student’s t-test (**P< 0.01).
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shown between the MDV-1 genome and the expressions
of PD-1 or PD-L1. The Spearman correlation coefficient
between the MDV-1 genome and PD-1 or PD-L1 was
0.18 (p= 0.64) and 0.050 (p= 0.90), respectively.Expressions of PD-1, PD-L1, IFNγ, and meq mRNA in the
spleens and tumor lesions derived from chickens
with MD in the field
To examine if immunoinhibitory molecules are expressed
in chickens developing MD in the field as observed inthose of experimentally infected chickens, we measured
the mRNA expressions of the meq gene and host genes in
the spleens and tumor lesions derived from chickens with
MD in the field (Figures 6 and 7). The expression of meq
RNA was observed in all of the field samples, and the
mean degree of the mRNA expressions of PD-1, PD-L1
and IFN-γ was also increased. Thus, in the case of chick-
ens with MD in the field, the mRNA expressions of PD-1
and PD-L1 were similar to those observed in experimen-
tally infected chickens.
in situ detection of PD-1, PD-L1, and meq mRNA in tumors
derived from MDV-infected chickens
To further determine if these host genes and the meq
gene were expressed in MD tumor cells, the histological
analysis was conducted by in situ hybridization. Since
the meq gene is abundantly expressed even in latently-
infected and transformed cells, it seems to be an optimal
marker for the detection of MDV-infected cells. In
tumor lesions, the meq transcripts were detected in cells
infiltrating into the interstitial of kidney tubule, and in
the spleen, meq transcripts were detected in white pulp




























































Figure 6 The mRNA expressions of PD-1 and PD-L1 in the
spleens of chickens with MD in the field. A total of 9 spleen
samples were collected from poultry farms. Two spleen samples
were collected from uninfected chickens and analyzed as controls.
The expressions of PD-1 (A), PD-L1 (B), IFN-γ (C), and meq (D) mRNA
were determined by real-time RT-PCR. The concentration of each
mRNA was normalized to that of β-actin mRNA. The extent of gene
expression (−fold) was calculated by dividing the value of each
sample by that of the value of each control (A-D). Error bars
represent standard deviations. The significant differences were


























































Figure 7 The mRNA expressions of PD-1 and PD-L1 in tumor
samples of chickens with MD in the field. A total of 4 tumor
samples were analyzed, and then, PBMCs from uninfected chickens
(n= 3) were also analyzed as controls. The expressions of PD-1 (A),
PD-L1 (B), IFN-γ (C), and meq (D) mRNA were determined by
real-time RT-PCR. The concentration of each mRNA was normalized
to that of β-actin mRNA. The extent of gene expression (−fold) was
calculated by dividing the value of each sample by that of the
value of each control (A-D). Error bars represent standard deviations.
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However, the PD-L1 transcripts were undetectable in the
spleen and tumor lesions by in situ hybridization ana-
lysis (data not shown). In order to confirm the mRNA
expressions of PD-1 and PD-L1 in tumor cells, nested
RT-PCR assays were performed by using laser-captured
microdissections (Figure 8B, C). The mRNA expressions
of PD-1 and PD-L1 were observed in tumor cells.
These results showed that both PD-1 and PD-L1 mRNAwere expressed in MD-derived tumor cells, and may
contribute to immune evasion of tumor cells from host
immune responses.Discussion
Recent studies have shown that host immunoinhibitory
factors, such as PD-1 and PD-L1, are exploited to evade
the immune response in chronic viral infections [26,27].
However, the function of the chicken PD-1/PD-L1 path-
way has not been well characterized. In order to evaluate
immunosuppressive function of PD-1 / PD-L1 pathway,
we determined the expression level of IFN-γ mRNA in
Lee1 cells which was co-cultured with DF-1 expressing
















Figure 8 The mRNA expressions of PD-1, PD-L1, and meq in
MD-derived tumor cells. (A) The expression of meq mRNA was
confirmed in serial sections of spleen and tumor samples from
experimentally infected chickens by in situ hybridization. Samples
were collected at 35 d.p.i. Positive signals were detected
mononuclear cells infiltrating into the renal tubulointerstitium (upper
panel) and in white pulp of spleen (lower panel). (B) Mononuclear
cells infiltrating into the renal tubulointerstitium and adjacent renal
cells, and white pulp of the spleens from infected or uninfected
chickens were captured by LMD. Panels show the targeted areas
before (left) and after (right) capture. (C) The expression of PD-1,
PD-L1, and meq mRNA was confirmed by RT-PCR using RNA isolated
from LMD-captured samples.
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suggesting that in case of chickens, PD-L1 also interacts
with PD-1, and then induces the immunosuppression
in PD-1-expressing cells, although further functional
analysis concerning the involvement of chickens PD-1/
PD-L1 pathway in immunosuppression and tumor for-
mation is required.The increase in PD-1 expression was reported in the
acute phase of HCV and lymphocytic choriomeningitis
virus (LCMV) infection [26,27]. In chickens experimen-
tally infected with MDV-1, the expression of PD-1
mRNA was increased in the early cytolytic phase, but
dramatically decreased following the onset of the latent
infection (Figure 3A). We previously reported that
MDV-1 induces apoptosis in CD4+ T cells during latent
phase, and the number of CD4+ T cells is decreased [28].
These observations suggest that PD-1 may be expressed
on the CD4+ T cells in the early cytolytic phase, and the
expression of PD-1 may be decreased by apoptosis of
CD4+ T cells before the onset of MDV latency. In con-
trast, the increase in PD-L1 mRNA expression was
observed in the latent phase (Figure 3B), suggesting that
PD-L1 contribute to the establishment and/or mainten-
ance of MDV-1 latency. Further studies, including the
identification of PD-1- and PD-L1-expressing cell popu-
lations and the expression analysis of PD-1 and PD-L1
on the protein level, are needed to clarify the role of the
PD-1/PD-L1 pathway in each phase of the infection.
In the case of HIV infection, some cytokines and viral
factors are considered to be responsible for the increase in
PD-1 and PD-L1 expressions [29], and it has been well
characterized that PD-L1 expression could be regulated by
IFN-γ [15]. In this study, the expression of IFN-γ mRNA
was increased in the early cytolytic phase, and this expres-
sion kinetics was similar to that of PD-1mRNA (Figure 3C),
suggesting that IFN-γ may be involved in the regulation of
PD-1 expression. However, the increase in the PD-1
mRNA expression was not observed in the secondary
cytolytic phase despite the increase in the IFN-γ expres-
sion. Thus, PD-1 expression may be induced as a conse-
quence of a negative feedback by IFN-γ stimulation during
the acute phase. On the contrary, the expression of PD-L1
mRNA was transiently elevated at 7 d.p.i., and then, the ex-
pression of IFN-γ mRNA was increased (Figure 3B, C). At
21 d.p.i., however, PD-L1 mRNA expression were
increased again although IFN-γ mRNA expression was
decreased (Figure 3B, C). The reason for these observa-
tions is unknown, but IFN-γ might gradually induce the
expression of PD-L1, which, in turn, cause immunosup-
pression and reduce the IFN-γ expression.
PD-L1 is expressed on a variety of human and murine
tumors [30], whereas tumor-infiltrating lymphocytes highly
express PD-1 [31]. In the case of nodular lymphocyte-
predominant Hodgkin lymphoma and angioimmunoblas-
tic T-cell lymphoma, tumor cells express PD-1 [32,33].
Moreover, tumor cells caused by HTLV-1 express both
PD-1 and PD-L1, and infiltrating T cells express PD-1,
suggesting that PD-L1 expressed on these neoplastic
CD4+ T cells induce immunosuppression of infiltrating
T cells and contribute to the immune evasion [34]. In
the case of MDV-1 infection, both PD-1 and PD-L1mRNA
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Figure 7A, B, Figure 8C, Additional file 1: Figure S1). Thus,
both PD-1 and PD-L1 may be expressed on MD tumor
cells, and may contribute to the immune evasion. Interest-
ingly, the expression of IFN-γ mRNA was increased in
tumor lesions (Figure 4C), and the expression of IFN-γ
mRNA in tumor lesions was higher than that in neighbor-
ing cells (data not shown). As a positive correlation
was shown between IFN-γ and PD-L1 mRNA expressions
(Figure 5B), IFN-γ may upregulate the expression of PD-L1
mRNA in tumor cells in an autocrine manner, and sub-
sequently, PD-L1 may enhance the immunosuppression.
Several groups reported that viral proteins such as Nef
protein of HIV and core protein of HCV cause the
increase in PD-1 expression [23,24]. In this study, we
focused on an MDV-1 oncoprotein, Meq, because Meq
regulates the expressions of various genes as a transcrip-
tion factor and is the most important viral factor related
to MD pathogenesis [8,35]. The expressions of meq
and PD-1 mRNA were transiently increased at 14 d.p.i
(Figure 3A, D), and in addition, the expression of meq
mRNA was positively correlated with PD-1 mRNA
expression in tumor lesions (Figure 5A), indicating that
Meq may regulate the expression of PD-1. However, a
positive correlation between the expression of meq and
PD-L1 was not observed in the spleens and tumors from
MDV-1-infected chickens. Since various viral factors are
involved in MDV-1 oncogenesis and pathogenesis [35],
other factors may correlate with the expressions of host
immunoinhibitory molecules.
In summary, we demonstrated that host immunoinhi-
bitory factors, PD-1 and PD-L1 were expressed in the
spleens of MDV-1-infected chickens, and their expres-
sions were showed different kinetics in each phase of the
infection (Additional file 2: Figure S2). Furthermore,
these factors were expressed in MD-derived tumors
(Additional file 2: Figure S2). These results suggest that
the PD-1/PD-L1 pathwayis involved in the immunosup-
pression and tumor formation by MDV-1.
Materials & methods
Cells
MD-derived lymphoblastoid cell lines, MSB1 [36] and
HP1 [37], and chicken T-cell line, Lee1, that was trans-
formed by REV and was established in our laboratory,
were maintained at 41°C, 5% CO2 in RPMI 1640 (Sigma-
Aldrich Co., St. Louis, USA) supplemented with 10%
heat-inactivated fetal bovine serum (FBS; Invitrogen,
Carlsbad, USA), 0.03%L-glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin and 50 μM 2-mercaptoethanol.
Chicken embryo fibroblasts (CEFs) were prepared from
11-day-old fertile eggs (Hokuren Co. Ltd, Sapporo, Japan)
and maintained at 37°C, 5% CO2 in Eagle’s Minimum Es-
sential Medium (Nissui, Tokyo, Japan) supplemented with10% Tryptose phosphate broth (Difco Laboratories,
Detroit, USA), 0.03% L-glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin and 0.1% NaHCO3. The immor-
talized CEF cell line, DF-1 [38], was maintained at 39°C,
5% CO2 in Dulbecco’s modified Eagle’s Medium (D-
MEM; Invitrogen) supplemented with 10% FBS, 0.03%L-
glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin
and 0.1% NaHCO3.
Chickens
Neonatal male White Leghorn chickens were purchased
from Hokuren Co. Ltd., and raised in isolators. The flock
was free of common poultry diseases and not vaccinated
against MDV. Feed and water were provided ad libitum.
Virus
A strain of very virulent MDV-1, RB1B [39], was obtained
from chicken kidney cell culture taken from experimen-
tally infected chickens in our laboratory. This virus was
propagated in CEFs and virus titer was determined by
plaque assays as described previously [40]. These infected
CEFs were used for the viral inoculation of chickens.
Strain RB1B at passage 12 was used in this study.
Virus inoculation and sample collection from
experimentally infected chickens
Two groups of 5-day-old chickens (36 chickens/group)
were inoculated intraperitoneally with either 2,000
plaque forming unit (PFU)/0.2 ml of RB1B or 0.2 ml of
PBS as untreated controls. Spleens and PBMCs were col-
lected from chickens in each group at 3, 7, 10, 14, 21,
28, and 35 d.p.i. Four samples per group were prepared
at each time point. Each sample was a composite from
two chickens at 3 d.p.i., because the number of cells col-
lected from one chicken was too few to be examined.
At 7 to 35 d.p.i. each sample was obtained from only
one chicken. In addition, tumor lesions, which were
observed in kidneys of MDV-1-infected chickens after
21 d.p.i., were also collected. This study was conducted
in accordance with guidelines of the Institutional Animal
Care and Use Committee of Hokkaido University, Japan.
Samples of chickens with MD in the field
Samples of chickens with MD in the field were collected
from poultry farms in Japan in 2010. Nine spleen- and
4 tumor-samples were used in this study. Of these tumor
samples, one was observed in a spleen and the others
were observed in livers.
Evaluation of viral loads in MDV-1-infected chickens
by real-time PCR
The absolute MDV-1 genome loads in the spleens and
tumor lesions were quantified using real-time PCR with
primers specific to the meq gene of MDV-1 as described
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shown in Table 1. Total cellular DNA was extracted using
the Sepa Gene kit (Sanko Jyunyaku Co. Ltd., Tokyo,
Japan) according to the manufacturer’s instructions. Real-
time PCR assays were performed using SYBR Premix
DimerEraser (Takara, Shiga, Japan) and a LightCycler 480
System II (Roche Diagnostics, Mannheim, Germany). The
chicken β-actin gene in each sample was also amplified
using a primer pair in Table 1. The β-actin gene was used
as a reference for the meq gene in each sample to express
the ratio between the two genes. Each sample was tested
in duplicate and the data were presented as average.
Total cellular RNA extraction and cDNA synthesis
Total cellular RNA was extracted from MSB1, HP1, and
Lee1 cells, PBMCs obtained from a healthy chicken, and
the spleen and tumor samples from experimentally
infected chickens and from chickens with MD in the
field, using the TRIZOL reagent (Invitrogen) according
to the manufacturer’s protocol. Each RNA sample was
treated with DNase I (Invitrogen) to remove residual
DNA, and cDNA was synthesized with Moloney murine
leukemia virus reverse transcriptase (Takara) as directed
by the manufacturer.
Expression analyses of the PD-1, PD-L1, IFN-γ, and meq
mRNA by real-time RT-PCR
Synthesized cDNA samples were used to determine the
mRNA expression levels of related factors by real-timeTable 1 Primers used for real-time PCR, real-time RT-PCR, and
Genes Analysis Types Sequence
meq real-time PCR Forward 5′-GTCCCC
real-time RT-PCR Reverse 5′-CGTCTG
LMD and RT-PCR
β-actin real-time PCR Forward 5′-GAGAA
Reverse 5′-CCTGAA
β-actin real-time RT-PCR Forward 5′-CCAAC
LMD and RT-PCR Reverse 5′-AGGCA
PD-1 real-time RT-PCR Forward 5′-GGACTA
LMD and nested RT-PCR (2nd PCR) Reverse 5′-TCTTTC
PD-1 LMD and nested RT-PCR (1st PCR) Forward 5′-ACACC
(1st PCR) Reverse 5′-TGCCAG
PD-L1 real-time RT-PCR Forward 5′-TTCAGG
LMD and nested RT-PCR (2nd PCR) Reverse 5′-CGTCTC
PD-L1 LMD and nested RT-PCR (1st PCR) Forward 5′-GGGAC
(1st PCR) Reverse 5′-GGTAA
IFN-γ real-time RT-PCR Forward 5′-CTCCCG
Reverse 5′-CTGAGART-PCR. The cDNA template was added to a total vol-
ume of 20 μl containing PCR buffer, oligonucleotide pri-
mers at 0.3 μM each of primer, and 10 μl of SYBR
Premix DimerEraser. Real-time RT-PCR assays were per-
formed using the LightCycler 480 System II (Roche
Diagnostics). The sequences of specific primers and
accession numbers for PD-1, PD-L1, and IFN-γ are
listed in Table 1, and meq as described above. The
cycling condition consists of initial template denatur-
ing at 95°C for 30 s, followed by amplification of tem-
plate for 35 cycles (β-actin) or 40 cycles (PD-1, PD-L1,
IFN-γ, and meq) of 95°C 5 s, 55°C for 30 s, and 72°C
for 30 s. A final melting curve analysis was performed
from 65°C to 95°C at a rate of 0.11°C/s (continuous
acquisition), with a final cooling to 40°C over 10 s. The
specificity of amplification was confirmed by melting
point analysis. The chicken β-actin gene in each sample
was also amplified using a primer pair in Table 1. The
β-actin gene was used as reference for target genes in
each sample to express the ratio between the two genes.
Serial dilutions of pGEM-T easy vector (Promega,
Madison, WI, USA) encoding each gene (1 × 10−6 to
1 ng/ml) were used to generate standard curves for
quantification. All primers were BLAST-searched against
chicken DNA sequences available in GenBank to ensure
amplification specificity and synthesized by Hokkaido
System Science (Sapporo, Japan). All samples were
tested in duplicate and the data were presented as aver-
age. Results were expressed in folds of each mRNALMD and RT-PCR
s Annealing temperature
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uninfected chickens.
in situ hybridization analysis
cRNA probes for the meq gene were synthesized in
the presence of digoxigenin-labbeled UTP by using the
DIG RNA labeling kit (Roche Diagnostics) according to the
manufacturer’s instructions. The primers used for
making each probe were M-S (5′-ATGTCTCAGGAGC-
CAGAGCCGGGCGCT-3′) and M-AS (5′-GGGGCATA-
GACGATGTGCTGCTGAG-3′) as described previously
[42]. The RNA probes (designated meq-sense and meq-
antisense) were stored at −80°C until use. The kidney
sample including tumor lesions and spleen samples were
fixed in 4% paraformaldehyde (PFA) overnight at 4°C and
paraffin sections (0.4 μm thick) were then prepared. Depar-
affinized, proteinase K-digested sections were incubated
with a prehybridization solution and then incubated with
hybridization buffer containing 50% formamide, 10 mM
Tris–HCl pH 7.4, 200 μg/ml tRNA, 1×Denhardt’s solution
(0.02% bovine serum albumin, 0.02% polyvinylpyrrolidone,
and 0.02% Ficoll PM400 (Amersham Pharmacia, Uppsala,
Sweden)), 10% dextran sulphate, 0.25% sodium dodecyl
sulphate, 1 mM ethylenediamine tetraacetic acid pH 8.0,
and 50 ng of sense or antisense RNA probe overnight at
58°C. The sections were incubated in an anti-DIG conju-
gated to alkaline phosphatase (1:400; Roche Diagnostics)
overnight at room temperature (RT). The signal was
detected by incubation of the sections with substrate solu-
tion containing nitroblue tetrazolium/ X-phosphate in a
solution composed of 100 mM Tris–HCl (pH 9.5),
100 mM NaCl, and 50 mM MgCl2 in a dark room over-
night at RT.
RT-PCR or nested RT-PCR assay of laser-captured
microdissections
The organs were fixed with 4% PFA and embedded to par-
affin for laser microdissection (LMD). LMD was performed
as previously reported [43]. First, 5 μm-thick paraffin sec-
tions were mounted on glass slides precoated with LMD
films (Meiwafosis, Tokyo, Japan), deparaffinized by xylene,
and dehydrated by alcohol. After staining with 1% toluidine
blue for 5 sec, LMD was performed on the normal renal
cortices and tumorigenic lesions by using Ls-Pro300 (Mei-
wafosis), according to the manufacturer’s protocol. All pro-
cedures were performed in RNase-free conditions.
Total RNA purified with RNAqueous (Ambion, Austin,
TX, USA) was reverse-transcribed to cDNA by using
SuperScript First-Strand Synthesis System for RT-PCR
(Invitrogen) according to the manufacturer’s protocol.
Synthesized cDNA was used for the PCR or nested PCR
with TAKARA-Taq (Takara) and appropriate primer
pairs (Table 1). Reactions were started with 94°C for
5 min, followed by 40 cycles of 94°C for 30 sec, eachannealing temperature (shown in Table 1) for 30 sec and
72°C for 30 sec, and f 72°C for 7 min, and finally kept at
4°C. Nested PCR analysis was performed by using 1 μl of
the 1st PCR reaction as a template and in a 20 μl reac-
tion mixture. The amplified fragments were separated on
agarose gels (2.0%) and visualized under ultraviolet light
after staining with ethidium bromide.
Analysis of the immunoinhibitory function in the
PD-1/PD-L pathway
For the construction of plasmids expressing PD-L1,




CATCTT-3′) that added a NotI site to the 5′ end and a
SalI site to the 3′ end for cloning. The amplified frag-
ment was digested with NotI and SalI and cloned into
the NotI and SalI sites of the pCMV-Tag1 vector (Strata-
gene, La Jolla, USA) to construct a plasmid expressing
PD-L1 (pCMV-PDL1).
DF-1 cells were seeded in 6-well plate at 2 × 106 cells
per well in 2.5 ml of D-MEM and incubated at 41°C
in 5% CO2 overnight. The cells in each well were trans-
fected with 5 μg of pCMV-PDL1 or pCMV-Tag1 using
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. At 36 h post transfection, these
DF-1 cells were co-cultured with Lee1 cells at 8 × 106
cells per well in 2.5 ml of RPMI 1640 and incubated at
41°C in 5% CO2 for 12 h. The expression levels of the
IFN-γ gene in co-cultured Lee1 cells were analyzed by
real-time RT-PCR as described above.
Western blotting
Transfected DF-1 cells were lysed at 48 h post transfec-
tion in 2×SDS buffer (150 mM Tris–HCl pH 6.8, 4%
SDS, 10% 2-mercaptoethanol, 20% glycerol and 0.2% bro-
mophenol blue) and boiled for 10 min. Samples were
separated on 15% SDS-polyacrylamide gels and trans-
ferred to the polyvinylidene difluoride membranes (Milli-
pore Corp., Bedford, MA, USA). The membranes were
blocked overnight at 4°C with 0.05% Tween 20 in phos-
phate-buffered saline (PBST) containing 3% skim milk.
The membranes were then incubated at RT for 1 h with
goat anti-myc tag antibody (abcam), washed 3 times with
PBST, and incubated at RT for 30 min with peroxidase-
conjugated rabbit anti-goat IgG (EY Laboratories). After
3 washes with PBST, the membranes were incubated
with 3,3′-diaminobenzidine tetrahydrochloride and cobalt
chloride substrates to visualize the peroxidase signal. The
blot was also probed with mouse anti-actin monoclonal
antibody (Millipore) followed by peroxidase-conjugated
goat anti-mouse IgG (H+L) (Jackson ImmunoRsearch)
as a loading and transfer control.
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Additional file 1: Figure S1. Comparison of tumor lesions observed in
kidneys with PBMCs obtained from infected or uninfected chickens. A
total of 9 tumor samples and PBMCs obtained from tumor-bearing
chickens were collected at 21, 28, and 35 d.p.i. (n= 2, 3, and 4,
respectively). Twelve PBMCs obtained from uninfected chickens at 21, 28,
and 35 d.p.i. The expressions of PD-1 (A) and PD-L1 (B) mRNA were
determined by real-time RT-PCR. The concentration of each mRNA was
normalized to that of β-actin mRNA. Error bars represent standard
deviations. The significant differences were determined by Student’s t-test
(*P< 0.05, **P< 0.01).
Additional file 2: Figure S2. Hypothetical model of PD-1 and PD-L1
involvement in chickens infected with MDV-1. The expression of PD-1 is
increased in the early cytolytic phase of the MDV infection, and may be
involved in MD pathogenesis including apoptosis of CD4+T cells. In
contrast, the expression of PD-L1 is increased in the latent phase, and
may contribute to the establishment and maintenance of MDV-1 latency.
Both PD-1 and PD-L1 are expressed on MD tumor cells in the secondary
cytolytic phase, and thereby may contribute to the immunosuppression,
immune evasion, and tumor development.
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